Technology News and Research

RSS

EACPR to host sessions on Cardiovascular prevention in Russia at EuroPRevent meeting

This year's EuroPRevent meeting, 14 -16 April, is taking full advantage of its Geneva location and the close proximity to the European Headquarters of the World Health Organisation, the World Heart Federation, the United European Football Association, and the International Olympics Committee.

7 Apr 2011

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

Neuros Medical, Inc., a medical device company, announced promising results today from their recently completed feasibility study. The study was the first human test of the Company's patented high frequency Electrical Nerve Block™ technology and focused on patients with chronic amputation pain which affects nearly one million patients in the U.S. During the study, four of the five patients reported their pain was reduced to zero.

7 Apr 2011

NIH awards HemoShear with Phase I SBIR grant to develop rodent liver system

HemoShear, LLC, is pleased to announce that it was awarded a Phase 1 Small Business Innovation Research grant from the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health.

7 Apr 2011

Cernostics, Definiens enter partnership to develop unique cancer assay

Definiens, the number one Health Image Intelligence company, and Cernostics, a life sciences firm specializing in advanced cancer diagnostics, today announced a partnership to develop a unique multiplexed assay tool for the diagnosis of cancer.

7 Apr 2011

Busy roads around pregnant woman's home increases likelihood of premature birth of baby

Babies are born earlier when their mothers live near a concentration of freeways and main roads, a study of 970 mothers and their newborn babies in Logan City, south of Brisbane, has found.

7 Apr 2011

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

VBL Therapeutics, a clinical-stage biotechnology company committed to the development of novel treatments for immune-inflammatory diseases and cancer, today announced preclinical data demonstrating VB-111's potential utility as a targeted cancer treatment.

7 Apr 2011

Brazil's Ministry of Health, PharmaPraxis sign deal to manufacture biologic drugs

PharmaPraxis, from Axis Biotec, Cryopraxis, Silvestre Labs and CellPraxis Group, announces the formalization of an agreement with Brazil's Ministry of Health to manufacture biologic drugs.

7 Apr 2011

Nuron Biotech announces acquisition of Wyeth's HibTITER vaccine assets

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has acquired assets relating to the vaccine HibTITER from Wyeth LLC, a wholly owned subsidiary of Pfizer Inc, for the U.S. and many other markets, including Japan and Korea. Financial terms of the sale were not disclosed.

7 Apr 2011

Avila announces successful completion of AVL-292 Phase 1a clinical studies for B-cell cancers

Avila Therapeutics, Inc., a biotechnology company developing novel targeted covalent drugs, today announced that it has successfully completed two Phase 1a clinical studies for AVL-292, its orally-available, selective inhibitor of Bruton's tyrosine kinase (Btk).

6 Apr 2011

Asuragen launches InformThyroid, a panel of molecular markers

Asuragen, Inc. announced today the launch of Inform™Thyroid, a panel of molecular markers used on Fine Needle Aspirates (FNA) of thyroid nodules to aid physicians in the management of thyroid cancer.

6 Apr 2011

Lupin grants Salix exclusive worldwide rights to rifaximin

Salix Pharmaceuticals, Ltd. today announced that as of March 31, 2011 Lupin Ltd. granted Salix exclusive worldwide rights (except for India) to exploit Lupin technology and technology jointly developed by Lupin and Salix for all rifaximin products for human use. This agreement expands the collaboration that Salix and Lupin entered into as of September 30, 2009.

6 Apr 2011

ImClone Systems initiates IMC-3C5 Phase 1 trial in patients with advanced solid tumours

Circadian Technologies announced today that its licensee ImClone Systems, a wholly-owned subsidiary of Eli Lilly and Company, has advised that it has commenced the first Phase 1 clinical trial of its fully-human monoclonal antibody IMC-3C5.

6 Apr 2011

Japanese MHLW approves Spectranetics LLD lead locking device

Spectranetics Corporation today announced that the Japanese Ministry of Health, Labor and Welfare granted approval for the LLD lead locking device, which is used for the removal of pacemaker and defibrillator cardiac leads.

6 Apr 2011

BioWa, OBT enter license agreement to advance ADCC programs

BioWa, Inc. and Oxford BioTherapeutics Ltd today announced that they have entered into a license agreement to provide OBT with access to BioWa's patented POTELLIGENT Technology platform for the development of antibody-dependent cellular cytotoxicity enhanced antibodies.

6 Apr 2011

Researchers develop new stroke rehabilitation devices

Devices which could be used to rehabilitate the arms and hands of people who have experienced a stroke have been developed by researchers at the University of Southampton.

6 Apr 2011

Record number of medicines for various cancers in clinical trials

A record 887 medicines for various of cancers are in clinical trials or awaiting Food and Drug Administration (FDA) review—well over double the number in the pipeline just six years ago, according to a report unveiled today by the Pharmaceutical Research and Manufacturers of America (PhRMA).

6 Apr 2011

Large majority of U.S. adults concerned about health care access

Seven of 10 adults think the U.S. health care system needs to be fundamentally changed or completely rebuilt, according to a Commonwealth Fund survey released today. The concerns reflect widespread experiences with access barriers, poorly coordinated care and growing costs.

6 Apr 2011

Gatherer Partnership is now part of rehabilitation facilities at The Royal Buckinghamshire Hospital

The Gatherer Partnership, conceived to develop innovative products that offer physiotherapists accurate and objective data for the management of neuromusculoskeletal conditions, has announced it is part of the respected rehabilitation facilities at The Royal Buckinghamshire Hospital (RBH).

6 Apr 2011

Aptiv Solutions creates Adaptive Clinical Trials Innovation Center

Aptiv Solutions, a global biopharmaceutical and medical device development services company, announced today the creation of an Adaptive Clinical Trials Innovation Center.

6 Apr 2011

First-of-its-kind map of recombination hotspots in a multi-celled organism

Researchers have zoomed in on mouse chromosomes to map hotspots of genetic recombination - sites where DNA breaks and reforms to shuffle genes. The findings of the scientists at the National Institutes of Health and Uniformed Services University of Health Sciences (USU) have the potential to improve the detection of genes linked to disease and to help understand the root causes of genetic abnormalities.

6 Apr 2011

Technology News and Research

EACPR to host sessions on Cardiovascular prevention in Russia at EuroPRevent meeting

Positive results from Neuros Medical Electrical Nerve Block technology study in chronic pain

NIH awards HemoShear with Phase I SBIR grant to develop rodent liver system

Cernostics, Definiens enter partnership to develop unique cancer assay

Busy roads around pregnant woman's home increases likelihood of premature birth of baby

VBL's VB-111 preclinical data against metastatic cancer presented at AACR meeting

Brazil's Ministry of Health, PharmaPraxis sign deal to manufacture biologic drugs

Nuron Biotech announces acquisition of Wyeth's HibTITER vaccine assets

Avila announces successful completion of AVL-292 Phase 1a clinical studies for B-cell cancers

Asuragen launches InformThyroid, a panel of molecular markers

Lupin grants Salix exclusive worldwide rights to rifaximin

ImClone Systems initiates IMC-3C5 Phase 1 trial in patients with advanced solid tumours

Japanese MHLW approves Spectranetics LLD lead locking device

BioWa, OBT enter license agreement to advance ADCC programs

Researchers develop new stroke rehabilitation devices

Record number of medicines for various cancers in clinical trials

Large majority of U.S. adults concerned about health care access

Gatherer Partnership is now part of rehabilitation facilities at The Royal Buckinghamshire Hospital

Aptiv Solutions creates Adaptive Clinical Trials Innovation Center

First-of-its-kind map of recombination hotspots in a multi-celled organism

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News